Skip to main content
Article thumbnail
Location of Repository

Effects of zinc supplementation on cognitive function in healthy middle-aged and older adults: the ZENITH study

By Elizabeth A. Maylor, Ellen E. A. Simpson, David L. Secker, Nathalie Meunier, Maud Andriollo-Sanchez, Angela Polito, Barbara Stewart-Knox, C. F. (Chris F.) McConville, Jacqueline M. O'Connor and Charles Coudray

Abstract

A randomised double-blind placebo-controlled design was employed to investigate the effects of Zn supplementation on cognitive function in 387 healthy adults aged 55–87 years. Several measures of visual memory, working memory, attention and reaction time were obtained using the Cambridge Automated Neuropsychological Test Battery at baseline and then after 3 and 6 months of 0 (placebo), 15 or 30 mg Zn/d. Younger adults (<70 years) performed significantly better on all tests than older adults (>70 years), and performance improved with practice on some measures. For two out of eight dependent variables, there were significant interactions indicating a beneficial effect (at 3 months only) of both 15 and 30 mg/d on one measure of spatial working memory and a detrimental effect of 15 mg/d on one measure of attention. Further work is required to establish whether these findings generalise to older adults in poorer mental and physical health and with less adequate Zn intake and status than the present sample

Topics: RA0421
Publisher: Cambridge University Press
Year: 2006
OAI identifier: oai:wrap.warwick.ac.uk:713

Suggested articles

Citations

  1. (1997). A neural systems approach to the cognitive psychology of ageing using the CANTAB battery.
  2. (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. doi
  3. (1998). A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: implications for theories of executive function and cognitive aging. doi
  4. (1997). Andre ´sP ,L o ´pez-Sobaler
  5. (1993). Are agerelated behavioral disorders improved by folate administration? doi
  6. (1999). Are copper, zinc and selenium in erythrocytes valuable biological indexes of nutrition and pathology? doi
  7. (2002). Assessment of neuropsychological function through use of the Cambridge Neuropsychological Testing Automated Battery (CANTAB): performance in 4- to 12-year-old children. doi
  8. (2000). Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. doi
  9. (2001). B vitamins, cognition, and aging: a review. doi
  10. (2000). Behavioral data and methodology issues in studies of zinc nutrition in humans.
  11. (2002). Brain-specific” nutrients: a memory cure?
  12. (2005). Brain, aging and neurodegeneration: role of zinc ion availability. doi
  13. (1994). Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. doi
  14. (2000). Can nutrient supplements modify brain function?
  15. (1996). CANTAB battery: proposed utility in neurotoxicology. doi
  16. (1991). CANTAB Parallel Battery: a suitable tool for investigating drug effects on cognition.
  17. (2000). Causes of iron and zinc deficiencies and their effects on brain.
  18. (1986). Computer-aided assessment of dementia: comparative studies of neuropsychological deficits in Alzheimer-type dementia and Parkinson’s disease.
  19. (1992). Computerised assessment in neuropsychiatry using CANTAB.
  20. (1983). Development and validation of a geriatric depression screening scale: a preliminary report. doi
  21. (1996). Double dissociations of memory and executive functions in working memory tasks following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man. doi
  22. (1986). Favier A
  23. (1996). Favier A & Franco A doi
  24. (2004). Herbal supplement use by persons aged over 50 years in Britain: frequently used herbs, concomitant use of herbs, nutritional supplements and prescription drugs, rate of informing doctors and potential for negative interactions. doi
  25. (2000). Human zinc deficiency. doi
  26. (2004). Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial.
  27. (2000). Institute of Medicine doi
  28. (1971). Interhemispheric differences in the localization of psychological processes in man.
  29. (1975). Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. doi
  30. (2000). Movement of zinc and its functional significance in the brain. doi
  31. (1996). Neuropsychiatyric applications of CANTAB.
  32. (2003). Normative data from the Cantab. I: development of executive function over the lifespan. doi
  33. (1997). Nutritional needs of seniors.
  34. (2000). Patterns of cognitive ageing. doi
  35. (1990). Planning and spatial working memory following frontal lobe lesions in man. doi
  36. (2001). Prevalence of zinc deficiency and its clinical relevance among hospitalised elderly. doi
  37. (2005). Screening and recruitment procedure of late-middle aged and older subjects: the ZENITH study. doi
  38. (1998). Test/re-test reliability of the CANTAB and ISPOCD neuropsychological batteries: theoretical and practical issues. doi
  39. (2002). The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS report no.
  40. (2001). The efficacy and safety of nutritional supplement use in a representative sample of adults in the North/South Ireland Food Consumption Survey. doi
  41. (1995). The neuropsychology of schizophrenia: relations with clinical and neurobiological dimensions. doi
  42. (2002). The role of zinc in the growth and development of children. doi
  43. (2002). Trace metals and the elderly. doi
  44. (1999). Use of computerized neuropsychological tests (CANTAB) to assess cognitive effects of antihypertensive drugs in the elderly. doi
  45. (2001). Zinc and cognitive development. doi
  46. (2000). Zinc and copper intakes and their major food sources for older adults in the 1994–96 continuing survey of food intakes by individuals (CSFII).
  47. (2000). Zinc as an essential micronutrient: a review. doi
  48. (1998). Zinc deficiency and child development.
  49. (1993). Zinc deficiency in elderly patients.
  50. (2005). Zinc intake and status in middle-aged and older European subjects: the ZENITH study. doi
  51. (2000). Zinc intake of the U.S. population: findings from the third national health and nutrition examination survey,
  52. (2003). Zinc is essential for brain development and function. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.